Criteria This award recognises the most innovative products that are widely available on the market. Eligible products must have been launched into the UK market after 1 January 2019. The judges will look for genuine innovation or product advancement leading to treatment for new indications, quicker or easier treatments, better treatment outcomes and enhanced patient safety, all backed up by sound evidence. Products must not have been entered into the Aesthetics Awards in previous years. Entry instructions You are encouraged to keep your entry concise and clear; bullet points and the use of formatting options such as bold, underlines and italics are encouraged to ensure your entry is easy to digest for judges. Please note that formatting cannot be copied and pasted from Word documents, so you should only add these when submitting your entry on the website. A strict character limit of 1,700 (including spaces) is enforced for each question and you must not exceed this; however, your entry does not have to meet it. References are included in the character count, although you may supply a reference list as part of your supplementary materials if it exceeds the character count. There will be no voting process and the winner will be decided by the judging panel. Important: please check your entry carefully for accuracy, grammar and spelling as this information may appear in the Aesthetics journal and on the Aesthetics website, as well as being considered as part of the judging process. There will be no opportunity to amend this once you have submitted your application online unless you pay a £100 +VAT administration fee and this information is received before shortlisting has begun.
MEP Technology® is a new class of cosmeceutical ingredient, it is the only non-hormonal oestrogen receptor stimulator. It works on key skin cells; fibroblasts and keratinocytes, to both promote and activate new oestrogen receptors, helping restore loss of collagen, hyaluronic acid and epidermal thickness in skin affected by menopause, without systemic effect.
The JUVÉDERM® VYCROSS collection has continued to grow in size over the years and Juvéderm® VOLUX is the latest addition to the collection, having been launched at an international level in June 2019. The treatment is specially formulated to restore and create volume in the chin and jaw area (2) Juvéderm VOLUX injectable gel is a safe, effective, and durable treatment for increasing chin projection and jaw volume and results in high patient satisfaction3.It also provides facial definition that can last up to 18-24 months(2)(3) , (individual results may vary)
Lasergen by Endor Technologies (elénzia UK distributor)
Ablative laser is widely used in dermatology and aesthetic medicine to treat anti-ageing and acne scars. After the treatment, the skin is damaged and inflamed and one of the most severe side effects is post-inflammatory hyperpigmentation that usually occurs in the treated area. Lasergen, by Endor Technologies, is an innovative new aftercare treatment for post ablative laser treatments making the results more effective. It keeps the skin protected and moisturized enhancing its recovery, it is clinically proven to reduce the appearance of post inflammatory hyperpigmentation and improves the reduction of acne scars compared with isolated laser, making the skin appear more uniform, youthful and healthy.
Benefits:
Improves post-inflammatory hyperpigmentation by 32%*
Reduces pigmentation intensity by 17*
Reduces acne scar volume by 8.5%*
Reduces redness and irritation by 5%*
Cares, protects and nourishes during regeneration
Morpheus8, is a unique, sub-dermal, adipose remodelling, radio-frequency (RF) device, which fractionally remodels and contours the face and body. The device delivers immediate results for patients, as well as more uniform, symmetrical, long-lasting and consistent outcomes by treating the subcutaneous fatty layers as well as the superficial layers of the skin. Morpheus8’s stand-out innovation comes from the use of fractionated RF energy into sub-dermal tissue. Typically, similar bipolar RF technologies on the market work exclusively in the superficial layers of the skin and patients may opt for surgery to reach the sub-dermal tissue for moderate and severe cases of laxity and wrinkles. However, Morpheus8 can work within the epidermis as well as the sub-dermal layers; providing more effective and longer-lasting results. With programmable penetration, depth and energy delivery, Morpheus8 is the ideal device for the treatment of fine lines & wrinkles, acne scars and general skin tone. 24 coated pins penetrate into the sub-dermal tissue, tightening fat and contracting connective tissue. Fractionated RF energy is scientifically proven to reduce wrinkles whilst rebuilding collagen and contracting the fatty tissue. It is minimally invasive with almost no downtime.
“CUSTOM
D.O.S.E acts like a mini skincare laboratory, combining lab grade formulation
and factory grade manufacturing into a machine that sits on the counter. As we
pursue our mission of beauty for all, we are inspired by the challenge of using
technology and design to create innovative beauty experiences custom made for
each consumer.” Guive Balooch, Global Vice President of L’Oréal’s Technology Incubator.
Aesthetics Media Ltd, 70 London Road, Regal House, Twickenham, TW1 3QS
Aesthetics Media Ltd, as part of Easyfairs
